Raleigh, N.C., March 22, 2012 - INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process^® for delivering reliable results, will conduct a conference call to discuss its fourth quarter financial results at 11 a.m. ET on Thursday, April 26, 2012.  The fourth quarter financial results also will be available on the Company's secure website on Wednesday, April 25, 2012.

To access the financial results and dial-in information for the conference call, a party must pre-register and certify that it is eligible to do so.  Access to the financial results and conference call will be available only to (1) holders of the Company's 11.5% Senior Notes due 2019, (2) hi-yield securities analysts and broker-dealers and (3) prospective investors that certify that they are qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended.  To receive information on how to pre-register and certify eligibility, parties must send an email to wlumpkin@incresearch.com  requesting access to the financial results and conference call information no later than April 25, 2012.  

About INC Research, LLC
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs  in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process^® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.

Contact:
INC Research, LLC
Willis Lumpkin, Treasurer, 919-341-3230